Free heme toxicity and its detoxification systems in human

Author(s): Kumar S, Bandyopadhyay U


Severe hemolysis or myolysis occurring during pathological states, such as sickle cell disease, ischemia reperfusion, and malaria results in high levels of free heme, causing undesirable toxicity leading to organ, tissue, and cellular injury. Free heme catalyzes the oxidation, covalent cross-linking and aggregate formation of protein and its degradation to small peptides. It also catalyzes the formation of cytotoxic lipid peroxide via lipid peroxidation and damages DNA through oxidative stress. Heme being a lipophilic molecule intercalates in the membrane and impairs lipid bilayers and organelles, such as mitochondria and nuclei, and destabilizes the cytoskeleton. Heme is a potent hemolytic agent and alters the conformation of cytoskeletal protein in red cells. Free heme causes endothelial cell injury, leading to vascular inflammatory disorders and stimulates the expression of intracellular adhesion molecules. Heme acts as a pro-inflammatory molecule and heme-induced inflammation is involved in the pathology of diverse conditions; such as renal failure, arteriosclerosis, and complications after artificial blood transfusion, peritoneal endometriosis, and heart transplant failure. Heme offers severe toxic effects to kidney, liver, central nervous system and cardiac tissue. Although heme oxygenase is primarily responsible to detoxify free heme but other extra heme oxygenase systems also play a significant role to detoxify heme. A brief account of free heme toxicity and its detoxification systems along with mechanistic details are presented.

Similar Articles

Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity

Author(s): Mohan S, Glushakov AV, Decurnou A, Narumiya S, Dore S

Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities

Author(s): Loboda A, Jazwa A, Grochot-Przeczek A, Rutkowski AJ, Cisowski J, et al.

mu-Opioid receptor attenuates Abeta oligomers-induced neurotoxicity through mTOR signaling

Author(s): Wang Y, Wang YX, Liu T, Law PY, Loh HH, et al.

Morphine protects for head trauma induced cognitive deficits in mice

Author(s): Zohar O, Getslev V, Miller AL, Schreiber S, Pick CG

Morphine modulation of the ubiquitin-proteasome complex is neuroprotective

Author(s): Rambhia S, Mantione KJ, Stefano GB, Cadet P

International Union of Pharmacology

Author(s): Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, et al.

Opiate receptor binding affected differentially by opiates and opioid peptides

Author(s): Childers SR, Creese I, Snowman AM, Synder SH

The role of opioid receptors in hypoxic preconditioning against seizures in brain

Author(s): Rubaj A, Gustaw K, ZgodziƄski W, Kleinrok Z, Sieklucka-Dziuba M